Both in Pharmaceuticals
Zevra Therapeutics vs Lexicon Pharmaceuticals
Over the past year ZVRA returned −1.1% and LXRX returned +5.9%; their daily moves had a correlation of 0.18.
ZVRA −1.1% LXRX +5.9%Growth of $1, one year, split-adjusted
| Metric | ZVRA | LXRX |
|---|---|---|
| Price | $10.10 | $1.44 |
| Market cap | $599.8M | $640.7M |
| Today | −1.75% | +1.41% |
| 1 month | +1.1% | −20.9% |
| 6 months | +0.5% | −10.0% |
| Year to date | +12.7% | +25.2% |
| 1 year | −0.4% | +7.5% |
| Revenue growth (YoY) | +53.3% | −97.6% |
| Gross margin | 96.2% | 94.4% |
| Net margin | 21.2% | −4591.8% |
| P/E (TTM) | 10.4× | — |
| Price / sales | 4.4× | 15.5× |
| Net cash | $221.6M | $139.2M |
| Dividend yield | — | — |
| Volatility (60d) | 44.1% | 51.9% |
| Short % of float | 10.8% | 11.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).